Effect of liraglutide on physical performance: a randomised, double-blind, controlled study in patiens with type 2 diabetes.

Trial Profile

Effect of liraglutide on physical performance: a randomised, double-blind, controlled study in patiens with type 2 diabetes.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Sep 2017

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms LIPER2
  • Most Recent Events

    • 15 Sep 2017 Primary endpoint (Fitness, assessed as maximum oxygen comsumption (VO2 max) on a cycle ergometer test) has not been met, according to the results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
    • 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
    • 05 Oct 2016 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top